Whats indias policy on funding non-elective/emergency procedures when the customer cant pay. Surely government funding will expand access?
Ann: Regulatory approval to launch CardioCel in India, page-55
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.140(1.08%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.50 | $13.14 | $559.5K | 42.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1180 | $13.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |